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From February to August 2003, 38 persons were
infected with Crimean-Congo hemorrhagic fever (CCHF)
virus in Mauritania; 35 of these persons were residents of
Nouakchott. The first patient was a young woman who
became ill shortly after butchering a goat. She transmitted
the infection to 15 persons in the hospital where she was
admitted and four members of her family. In Nouakchott,
two disease clusters and 11 isolated cases were identified.
The case-fatality ratio was 28.6%. Of the patients not
infected by the first case-patient, almost half were butchers,
which suggests that the primary mode of animal-to-human
transmission was direct contact with blood of infected ani-
mals. The hospital outbreak alerted health authorities to
sporadic cases that occurred in the following weeks, which
would have probably gone otherwise unnoticed. Studies
must be conducted to determine the potential risk for con-
tinued sporadic outbreaks of CCHF in humans and to pro-
pose prevention measures.
C
rimean-Congo hemorrhagic fever (CCHF), an acute
viral disease in humans, is characterized by extensive
ecchymoses, bleeding, and hepatic dysfunction and is
associated with a 30% case-fatality ratio (1–3). It is caused
by CCHF virus (genus Nairovirus, family Bunyaviridae).
CCHF is a zoonosis transmitted to large and small
mammals and birds by ticks. Although the virus has been
isolated from several genera and species of ixodid ticks,
the main group of vectors involved in CCHF virus trans-
mission appears to be ticks of the genus Hyalomma
(1,4–6). Immature ticks acquire the virus by feeding on
infected small vertebrates. Once infected, they remain
infected throughout their development and, when they are
mature, transmit the infection to large animals, such as
livestock. Transovarian transmission has also been demon-
strated (7,8). 
Hyalomma ticks are widespread throughout Europe,
Asia, the Middle East, eastern Asia, and Africa, and evi-
dence of CCHF virus has been found in all these regions.
The virus is transmitted to humans by the bite of infected
ticks, direct contact with blood or infected tissues from
viremic animals, and direct contact with the blood or
secretions of an infected person. Animals are viremic for
≈1 week after infection but have only a moderate fever,
which often goes unnoticed (9). The incubation period is
usually 5–6 days after contact with blood (1). As with
other hemorrhagic fevers, such as Ebola fever, several
nosocomial CCHF outbreaks have been described
(3,10–12). A lack of resources and hygiene in medical
facilities plays a role in amplifying transmission (10,11).
Hospitalized patients often bleed and are highly viremic; in
overcrowded hospitals, where no isolation measures are
taken, these patients can infect attending medical person-
nel as well as other patients who come in contact with their
blood or vomit. 
Epidemics of CCHF were first recorded in the Balkans
in 1944 (4) and in Africa in 1956 (13). The first human
case of hemorrhagic fever due to CCHF virus in West
Africa was identified and serologically confirmed in
Mauritania in 1983 (14) in a patient from Selibaby
(Guidimakha region) (Figure 1). 
In February 2003, six persons, including one physician
and two nurses, were admitted to Nouakchott National
Hospital for fever and hemorrhage. Three persons died.
Serum samples from these patients tested positive for
CCHF by immunoglobulin (Ig) M detection by enzyme-
linked immunosorbent assay (ELISA), reverse transcrip-
tion–polymerase chain reaction (RT-PCR), or isolation. We
report on an investigation of the magnitude and conditions
of emergence of this first urban CCHF outbreak in
Mauritania.
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Case Definitions
In the field, a probable case was defined as occurring in
someone who had an unexplained fever and acute hemor-
rhagic symptoms, such as petechiae, epistaxis, gingival
hemorrhages, hematemesis, or melena, or who had an
unexplained fever and contact with another case-patient.
For the purpose of this report, a case-patient was defined
as someone who fit the definition of a probable case and
who had a positive laboratory result or who had fever and
hemorrhagic signs, was in contact with a virologically con-
firmed case-patient, and died before sampling. One
healthy person with no obvious recent history of disease,
who was investigated as a contact, had anti-CCHF virus
IgM and was included as case-patient.
Case Findings and Management
Once the first cases of CCHF were confirmed, infor-
mation on the disease was sent to all health facilities in the
country. Persons with probable cases who had hemorrhag-
ic signs and reported to health facilities were isolated. In
Nouakchott, an isolation ward was opened, where strict
measures of hygiene were followed. Blood was drawn
from each patient on the day of admission after an initial
interview and drawn again 1 week later. Blood samples
were sent to the Institut Pasteur laboratory in Dakar
(Senegal) for testing. In addition, home visits were con-
ducted. Relatives and neighbors were interviewed, and
patients with probable cases were identified and sent to the
isolation ward. Blood samples were obtained from con-
tacts of patients, and these persons were monitored. A
blood sample was taken from patients on day 21, and they
were discharged when IgG was detected in this sample.
Animals
Serum samples were collected from domestic sheep
and goats living near the patients in Nouakchott and in
Azlat (Brakna region), where the family of the first identi-
fied patient was living. Ticks were collected from domes-
tic animals (goats, sheep, and dogs) living in close
proximity to patients in Nouakchott and from animals in
livestock markets. Ticks collected from each animal were
kept alive in separate vials covered with gauze. The col-
lections were frozen in liquid nitrogen on site and taken to
the Institut Pasteur of Dakar. Ticks were sorted on a cold
table and then pooled according to stage, sex, host, species,
and geographic origin.
Diagnostic Testing
Diagnosis of CCHF virus infection in humans, animals,
and ticks was made at the Institut Pasteur of Dakar (WHO
Collaborative Centre for arboviruses and viral hemorrhag-
ic fever) by serologic testing (IgM capture and IgG indirect
ELISA) (15), RT-PCR on S segment (16) with Titan One-
Step RT-PCR System (Roche Diagnostics, Mannheim,
Germany), according to the recommendations of the man-
ufacturer, or viral isolation.
Serum or tick supernatant was injected into the cere-
brum of 2- to 3-day-old mice and into Vero cell culture.
The mice were observed for 2 weeks. If mice died or
became sick, their brains were removed for injection into
Vero cells and for virus identification. CCHF virus was
confirmed by indirect immunofluorescence antibody test,
with polyclonal and monoclonal antibodies. Identity of
virus isolates was confirmed by complement fixation.
The PCR product (538 base pairs) was purified on
agarose gel and directly sequenced by Genome Express
(Meylan, France). We compared the resulting sequence
with those available in the GenBank database, with
BLAST tool. 
Statistical Analysis
Data were anonymously analyzed with Stata software
version 6.0 (Stata Corporation, College Station, TX).
Median and range of quantitative variables were calculat-
ed. For qualitative variables, proportions were calculated.
To compare qualitative variables, the chi-square test was
used. A p value < 0.05 was considered significant.
Results
From February to August 2003, the field case definition
was met by 63 persons, 59 of whom had blood samples
collected for diagnostic testing. Among them, 33 had a
positive laboratory test for CCHF virus infection. Four
additional patients met the case definition but died before
samples were obtained.
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Figure 1. Map of southern Mauritania.During the acute phase of the epidemic, 84 asympto-
matic case contacts were interviewed and sampled. Only
one (1.2%) was found positive and was considered to have
a case of CCHF. The distribution of the 38 cases, accord-
ing to the laboratory test results, is shown in Table 1.
Human Outbreak
First Patient and Initial Outbreak Cluster
The first patient to be identified (patient 1) was a 30-
year-old pregnant woman who became ill on February 12,
2003, 7 days after she had butchered a goat. She was taken
to the Nouakchott National Hospital by her relatives on the
night of February 17. She had a severe nosebleed, which
did not respond to treatment. She was extremely agitated,
and her blood was spread across the small room where she
was hospitalized, in the presence of other patients and their
relatives. She died on February 18, 2003. 
The doctor and the nurse who examined patient 1, one
nursing student, and two hospital workers who were work-
ing in the emergency ward at the time were infected, and
all had fatal cases. Of the 10 hospital patients and visitors
infected in the ward where patient 1 was treated, 1 died.
Four family members of patient 1 were directly infected.
From these infected persons, two secondary cases
occurred. 
During the investigation, serum samples were collected
from the three surviving goats from the same flock as the
goat that the first case-patient had butchered. Anti-CCHF
virus IgG was detected in the serum of one of the goats.
These animals had come from Azlat, in the Brakna region,
the native village of the index case-patient’s family, where
the investigation continued. Serologic evidence for CCHF
virus infection was found in 4 of 25 sampled sheep (CCHF
IgG-positive).
Evolution of the Epidemic
In Nouakchott, an outbreak of 35 cases of CCHF
occurred between February 12 and August 24, 2003
(Figure 2). Two clusters and 11 isolated cases were identi-
fied (Appendix Figures, available online at
http://www.cdc.gov/ncidod/EID/vol10no12/04-0535-
G.htm). The main cluster (cluster 1), made up of 22 per-
sons, was caused by contact with patient 1; this cluster
included patient 1, members of her family, the hospital
staff, and patients in the emergency ward. Cluster 2 com-
prised two persons who were infected after slaughtering a
sheep. 
All of these patients were living in Nouakchott during
the month preceding their illness onset. The male-to-
female ratio of patients was 1.7 (22/13); the mean age was
35.7 years (median = 31 years, range = 19–60 years). Of
the 13 persons who did not belong to cluster 1 and for
whom information was recorded, 6 (46.2%) were butchers,
and 1 was in the habit of carrying animals in his truck. Of
the nine women of childbearing age, two were pregnant. 
The overall case-fatality ratio was 28.6%, 42.9%
among patients likely infected by an animal and 19.0%
among patients likely infected through person-to-person
transmission. Death occurred 3–11 days after onset (medi-
an = 4 days). The male-to-female ratio (2.3) and median
age (30 years) for deceased persons were comparable to
those of survivors, but the time between infection and dis-
ease onset was shorter (80% of deceased patients had incu-
bation periods <6 days before onset, compared to 29% of
survivors;  χ2 = 3.997, p = 0.046) (Table 2). In other
regions, three case-patients were detected, including two
housewives from the Brakna region (Aleg and Maghta
Lahjar), one of whom died, and one butcher from Aioun El
Atrous, in the Hodh El Gharbi region. 
Of 14 confirmed patients tested on days 4 and 5, 10
(71%) tested positive for IgM; these antibodies were sys-
tematically detected in samples taken on day 6 or later. RT-
PCR was performed for 16 confirmed cases. The results
were positive for 10 patients for whom the median delay
between the date of onset and the sampling date was 5 days
(range 3–7 days). The five patients with negative results
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Figure 2: Distribution of CCHF cases by week of onset, Mauritania,
February–August 2003.and known delay (between date of onset and sampling) had
been sampled on days 4 and 5 after onset. Isolation was
successful on samples taken days 4–7 after onset (four
samples with known dates of onset and sampling). For one
patient who died on day 4, the results of ELISA and RT-
PCR tests performed on blood samples taken the same day
were negative, but virus isolation was successful.
Animals
Serum samples from 72 animals living near case-
patients in Nouakchott were obtained and tested. In addi-
tion, serum samples from 25 animals belonging to the
family of patient 1 in their native village, Azlat, Brakna,
were analyzed. In Nouakchott, samples were obtained
from animals living near patient 1, patients who were con-
taminated at the hospital (case-patients 13, 14, and 16),
and patients with a separate source of infection (case-
patients 23, 24, and 27). Of the 72 animals, 13 (18.1%)
were positive for CCHF virus IgG by ELISA(Table 3). No
animal was positive for IgM. 
Tick Survey
The local department of public health treated the
domestic animals in patients’ homes with acaricidal treat-
ments soon after cases were confirmed. As a result, we
were not able to collect a sufficient number of ticks in
these locations, and we extended our tick collection to
include the animals belonging to the patients’ neighbors.
We collected 119 ticks from 70 domestic animals living
near patients.
In addition, 259 ticks were collected from animals in
livestock markets. Two genera and six species of ticks
were collected (Table 4). Members of the genus
Hyalomma, the principal vector of CCHF virus, were
found in the same proportion as genus Rhipicephalus.
Hyalomma ticks were the main species collected in the
market places, whereas Rhipicephalus were mostly found
in patients’ homes. None of the ticks collected in the
patients’ neighborhoods were positive for CCHF virus.
The presence of CCHF virus or genome was detected on
Rhipicephalus evertsi evertsi ticks collected on three sheep
from the markets. Two of these three sheep had been
imported from the Hodh el Gharbi region (Figure 1).
Isolated Strains
The positions of nucleotides in the entire S segment of
the CCHF virus isolated from patients infected in
Nouakchott National Hospital are presented in Figure 3.
The strain HD 168662, which is representative of human
isolates obtained from this study, shows 82.1 % nucleotide
identity with the strain HD 49199, which was isolated
from a human patient in Mauritania in 1987. All strains
isolated from patients infected during this outbreak had
100% homology.
Discussion
This study is the first to report CCHF virus in
Nouakchott, the capital of Mauritania. The circulation of
CCHF virus and the high prevalence of infected animals
and ticks have been well documented in Mauritanian farm-
ing areas since 1983 (5,17,18). However, the disease had
not yet been reported in Nouakchott, despite the fact that
livestock are regularly transported there from farming
areas. 
The index case-patients came from six of the nine dis-
tricts in Nouakchott, which suggests that a large part of the
city was affected by the disease. In Mauritania, as in other
developing countries, a demographic transition occurred in
recent years, characterized by massive rural-to-urban
migration. In Nouakchott, in one generation, from 1977 to
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Nomadic habits, such as possessing domestic animals,
have been maintained. In cities with a high population den-
sity, especially in areas where zoonoses are prevalent, this
practice represents a major risk for human populations. 
Wilson (19) and Gonzalez (9) demonstrated that West
African sheep play a central role in the maintenance cycle
of CCHF virus in disease-endemic areas because they
serve as host for both the virus and the tick vector. These
researchers also showed that even sheep that were infected
previously and had anti-CCHF virus IgG can be reinfected
and transmit the virus. In Nouakchott, sheep and goats are
the most numerous domestic animals, and they live in
close proximity to humans.
In Nouakchott, direct contact with blood of an infected
animal seems to have been the primary mode of transmis-
sion from animals to humans. During the outbreak, half of
the index patients were butchers, and a number were
housewives, which suggests that handling freshly cut meat
is a risk for infection. This hypothesis seemed to be con-
firmed by a survey conducted in June 2003 by the Centre
National d’Hygiène in Mauritania. During this survey,
anti-CCHF virus IgG was detected among 20 (7.0%) of
287 abattoir workers in Nouakchott (unpub. data).
The outbreak was initially observed in a hospital emer-
gency ward, where the index patient infected five hospital
staff members and 10 patients and visitors. The risk for
nosocomial transmission of CCHF virus has been previ-
ously reported in Albania, Pakistan, Iraq, South Africa, and
Dubai (3,11–12,20–24). In all of these reports, infected
persons were heavily exposed to the blood of a patient. The
same observation was made during this outbreak: the 10
patients and visitors who spent the night in the same room
as the index patient, as well as the five health workers who
died, had close contact with her blood. Secondary cases
occurred only among her family and hospital contacts. In
that cluster, two secondary contacts tested positive for
CCHF virus. No other secondary cases occurred. This
observation confirms other reports (11,12) that suggest a
heavy exposure is needed for infection to occur. This find-
ing is consistent with the hypothesis that subpopulations of
virus adapted to a host are selected after passage through
another vertebrate host. According to Gonzalez (25), these
subpopulations seem to be less virulent and might have an
altered capacity of transmission. 
Although the difference between the two groups was
not significant, probably due to lack of statistical power,
we observed that the case-fatality ratio among patients
contaminated by an animal was higher than the case-fatal-
ity ratio among secondary cases. This result could be due
to a decrease in virulence after passage to humans, but it
could also be explained by the fact that, while all patients
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 12, December 2004 2147
Crimean-Congo Hemorrhagic Fever, Mauritania
Figure 3. Comparison of partial sequences (465 base pairs) of the
S segment of Crimean-Congo hemorrhagic fever virus isolated in
Mauritania. The BLAST tool was used and positions of nucleotides
in the entire S segment are shown. The strain HD 168662, which
is representative of human isolates obtained from this study,
shows 82.1% nucleotide identity with the strain HD 49199, isolat-
ed from a human case-patient in Mauritania in 1988.in cluster 1, where the person-to-person transmission was
observed, were detected, only the most severe cases result-
ing from contact with animals were reported. 
We also observed that the incubation period was short-
er for patients with fatal cases, which suggests that viremic
load was higher. Half of the deaths occurred before day 4
after onset, when one third of seroconversions had not yet
been observed, which confirms that ELISAcannot be used
alone to diagnose CCHF (26,27). More than 5 days after
onset, ELISA (IgM capture) systematically diagnosed
infection. During the first 5 days, CCHF infection was
confirmed by RT-PCR or isolation. 
We investigated four patients who had most likely been
infected by animals. One of the patients came from the
Brakna region, where the presence of infected animals was
confirmed. Animals suspected of infecting the other three
patients had already been slaughtered and could not be
investigated. In addition, none of the animals in the neigh-
borhoods surrounding these patients’homes tested positive
for IgM against CCHF virus, despite the fact that IgM
remains elevated for 40 days after infection (9). However,
this finding could be explained by the fact that very few
ticks were found, and horizontal transmission from animal
to animal does not occur in the absence of tick vectors.
During our investigation, we found anti-CCHF virus IgG
in 8 of 44 animals (2 of 23 goats, 6 of 21 sheep) that lived
near the case-patients for whom person-to-person trans-
mission at the hospital was well documented. These ani-
mals were therefore not involved in human infection. This
finding suggests that the CCHF virus has widely spread
among animal populations in Nouakchott.
Ticks were collected in neighborhoods surrounding the
patients’homes and in marketplaces. During these investi-
gations, R. evertsi evertsi was the only species found to be
infected by the CCHF virus. Even if Hyalomma is the main
vector for CCHF, R. evertsi evertsi may play a role in
CCHF virus transmission (6).
Genetic analyses indicated that viruses isolated from
case-patients linked to the nosocomial outbreak, the spo-
radic cases that occurred in the following weeks, and ticks
all belonged to the same cluster (data not shown). Only
two strains that caused fatal infections have been isolated
from humans in Mauritania. The strain isolated during the
2003 outbreak was different from the strain previously
responsible for human cases, but it was closely related to a
virus previously isolated from ticks in Mauritania. The sta-
bility of the strain structure and the high prevalence CCHF
antibodies in abattoir workers indicate that the CCHF virus
is well established in Mauritania.
The 2003 epidemic was probably discovered because
the outbreak occurred in a hospital. The hospital setting
amplified the severity of transmission—with 19 secondary
and 2 tertiary cases connected to the hospitalized index
case-patient. This factor, in addition to the simultaneous
death of a doctor and a nurse working in the same ward,
alerted the medical authorities. The sporadic cases that
occurred in Nouakchott in the following weeks (13 cases,
5 deaths) would have probably gone unnoticed if health
personnel had not already been alerted because of the hos-
pital outbreak. 
CCHF may have emerged recently in Nouakchott, how-
ever. The rainy season normally lasts from June to
September, but in 2002, the rains were scarce (<200 mm in
farming areas) and pastures were difficult to find. As a
result, farmers had to lead their flocks near large cities to
feed them with imported food, increasing human exposure
to infected animals and therefore the risk for infection.
Because urban populations can access health facilities rel-
atively easily, the risk for nosocomial transmission in over-
crowded hospitals, where basic hygiene measures are not
followed, was high.
Regardless of whether CCHF was recently imported or
has been long established in Nouakchott, no human case
had been reported before 2003. Studies should be conduct-
ed to determine the potential risk for continued sporadic
and clustered outbreaks of CCHF in humans and to identi-
fy prevention measures.
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